Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
16.81
-0.18 (-1.06%)
At close: May 12, 2025, 4:00 PM
16.81
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $916.03 million as of May 12, 2025. Its market cap has decreased by -19.90% in one year.
Market Cap
916.03M
Enterprise Value
626.28M
1-Year Change
-19.90%
Ranking
Category
Stock Price
$16.81
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $916.03M, an increase of 43.85%. That is a compound annual growth rate of 8.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 925.84M | -10.95% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |